The Current State of Niacin in Cardiovascular Disease Prevention: A Systematic Review and Meta-Regression
Conclusions:
The consensus perspective derived from available clinical data supports that niacin reduces CVD events and, further, that this may occur through a mechanism not reflected by changes in high-density lipoprotein cholesterol concentration.
Source: Journal of the American College of Cardiology - Category: Cardiology Authors: Paul M. Lavigne, Richard H. Karas Tags: Cardiometabolic Risk Source Type: research
More News: Cardiology | Cardiovascular | Cholesterol | Clinical Trials | Coronary Heart Disease | Heart | Heart Disease | Metabolic Syndrome | Niacin | Simvastatin | Statin Therapy | Stroke | Study | Vitamin B3 | Zocor